financetom
Business
financetom
/
Business
/
M/I Homes Q3 revenue misses estimates on lower contract volume
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
M/I Homes Q3 revenue misses estimates on lower contract volume
Oct 22, 2025 4:56 AM

Overview

* M/I Homes ( MHO ) Q3 revenue declined 1% to $1.1 bln, missing analyst expectations

* Company delivered a record 2,296 homes in Q3, despite challenging market conditions

* M/I Homes ( MHO ) repurchased $50 mln of common stock and received a credit rating upgrade

Outlook

* Company notes market conditions remain volatile but is confident in housing industry fundamentals

* M/I Homes ( MHO ) highlights strong financial position with credit rating upgrade and facility extension

Result Drivers

* RECORD HOME DELIVERIES - Delivered a record 2,296 homes despite challenging market conditions

* DECREASED NEW CONTRACTS - New contracts fell 6% to 1,908 compared to last year's third quarter

* BACKLOG DECLINE - Backlog units decreased 31% with a 30% drop in sales value

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Miss $1.10 $1.15

Revenue bln bln (2

Analysts

)

Q3 EPS $3.92

Q3 Net $106.50

Income mln

Analyst Coverage

* The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the homebuilding peer group is "buy."

* Wall Street's median 12-month price target for M/I Homes Inc ( MHO ) is $151.00, about 7.1% above its October 21 closing price of $140.30

* The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 6 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioNTech Advances On Positive Phase 3 Breast Cancer Drug Data
BioNTech Advances On Positive Phase 3 Breast Cancer Drug Data
Sep 5, 2025
On Friday, BioNTech SE ( BNTX ) and its partner Duality Biologics (Suzhou) Co., Ltd. released topline data from a Phase 3 trial in China evaluating trastuzumab pamirtecan (BNT323/DB-1303) versus trastuzumab emtansine (T-DM1) for HER2-positive unresectable or metastatic breast cancer patients who have previously received trastuzumab and a taxane-based chemotherapy. The trial met its primary endpoint of progression-free survival at...
WHO adds GLP-1 drugs for diabetes, others to essential medicines list
WHO adds GLP-1 drugs for diabetes, others to essential medicines list
Sep 5, 2025
LONDON, Sept 5 (Reuters) - The World Health Organization has added GLP-1 drugs to treat diabetes to its essential medicines list alongside treatments for cystic fibrosis and cancer, and said it hopes this will help improve global access to the costly drugs. The list, consisting of 523 medicines for adults and 374 for children, is a catalogue of the drugs...
Mobile-health Network, Jospong Group to Launch Digital Health Platform in Ghana
Mobile-health Network, Jospong Group to Launch Digital Health Platform in Ghana
Sep 5, 2025
09:08 AM EDT, 09/05/2025 (MT Newswires) -- Mobile-health Network Solutions ( MNDR ) has signed a memorandum of understanding with Jospong Group to create a joint venture for launching Mobile-health's artificial intelligence-powered digital health platform in Ghana, the companies said Friday. Financial terms were not disclosed. The collaboration integrates Mobile-health's telehealth and AI-driven healthcare technology with Jospong's capital resources and...
Ryan Specialty Launches New Collateralized Reinsurance Vehicle
Ryan Specialty Launches New Collateralized Reinsurance Vehicle
Sep 5, 2025
09:06 AM EDT, 09/05/2025 (MT Newswires) -- Ryan Specialty ( RYAN ) said Friday that it has launched a new collateralized reinsurance vehicle called Ryan Alternative Capital Re, via a strategic trading relationship with AXIS Capital ( AXS/PE ) . The new reinsurance vehicle has raised about $400 million in committed capital from funds managed by Flexpoint Ford and Sixth...
Copyright 2023-2026 - www.financetom.com All Rights Reserved